Abstract. Different enantiopure terminal epoxides or bromohydrins have chemoselectively been synthesised in one-pot starting from the corresponding α-bromoketones through alcohol dehydrogenase (ADH)-catalysed processes adding an organic co-solvent and tuning appropriately the medium pH and the temperature. Thus, at neutral pH enantiopure bromohydrins were obtained while using basic conditions (pH 9.5-10) epoxides were isolated as the main product. Furthermore, by simple selection of the biocatalyst, chemo-and stereodivergent transformations were achieved to obtain, e.g. enantiopure prolinol or piperidin-3-ol.
Enantiopure terminal halohydrins and epoxides are valuable functionalities in pharmaceutical industry and natural products synthesis due to their high reactivity allowing the obtaining of a huge variety of compounds. [1] In the last three decades, organo-and transition metal-based approaches have successfully been developed to synthesise these derivatives. [2] Otherwise, environmental friendly enzymatic processes leading to enantioenriched oxiranes and halohydrins have been less developed.
[3] Among them, kinetic resolutions using epoxide hydrolases (EHs) [4] and halohydrin dehalogenases (Hhes) [5] have been employed to catalyse the regio-and enantioselective oxirane ring-opening with H 2 O or other nucleophiles, affording the enantioenriched substrate and product with a 50% maximum yield. Recently, an elegant chemoenzymatic dynamic kinetic resolution procedure leading to aromatic terminal epoxides has been published. [6] Thus, coupling an Ir catalyst which promoted the racemisation of the halohydrins with an Hhe, several (R)-oxiranes could be achieved with moderate to high conversions and high enantioselectivities. Another approach has been the P450 monooxygenase-catalysed asymmetric epoxidation of terminal olefins. [7] Halohydrins have been obtained through stereoselective reduction of α-haloketones using alcohol dehydrogenases (ADHs). [8] Likewise, terminal epoxides have also been prepared through ADH-based sequential or cascade protocols. [9] In those systems, a terminal α-chloroketone was stereoselectively reduced with an ADH to the corresponding enantiopure chlorohydrin that subsequently cyclisised through Hhe- [9a-c] or base-catalysed [9d] intramolecular S N 2 reaction, leading to the epoxides with moderate to high conversions and excellent ees. Similarly, a "designercell"-based two-step procedure was developed to synthesise (S)-octene oxide. [10] It is noteworthy that pH around 13 was set in order to accomplish the oxirane ring-formation, [9d,10] that can be incompatible with other functionalities.
With this scenario we assumed that employing α-bromoketones [10, 11] instead of α-chloroketones, we could synthesise enantioenriched terminal oxiranes or bromohydrins in one-pot by simple use of a catalyst (an ADH) and a catalytic amount of cofactor employing 2-propanol to recycle it ("substratecoupled" approach) [12] at suitable pH conditions for the enzyme (Scheme 1). Furthermore, an application to obtain N-heterocyclic compounds is also shown. For this purpose, we chose 1-bromooctan-2-one (1a) [10] as model substrate. Using Lactobacillus brevis ADH (LBADH) [13] as catalyst at pH 7.5, only 10% of enantiopure (S)-epoxide 3a was obtained after 24 h, so Tris.SO 4 buffers ranging from pH 7.5 until 10 were tested (see Supporting Information). Obviously, the best conversion into 3a (47%) was found with the highest pH, although we observed that other minor compounds were also formed. In this sense, blank experiments demonstrated that the corresponding hydroxyketone (4a) was formed by S N 2 reaction over substrate 1a, and diol 5a appeared due to the ADHcatalysed reduction of 4a. [14] To circumvent this fact it was envisaged that an amount of a waterimmiscible solvent could result in a reservoir for both substrate and products (Scheme 2). Consequently, several organic solvents such as npentane, n-hexane, cyclohexane, n-heptane and ndecane were assayed at 5% v v -1 leading to almost exclusive formation of 2a and 3a after 24 h, although the cyclisation rate diminished (see Supporting Information). Since no relevant difference was noticed among them, n-hexane was selected as the organic co-solvent. The addition of the organic phase was advantageous to suppress the undesired S N 2 reaction over α-bromoketone 1a, but also delayed the enzymatic reduction to obtain 2a and the ring-closure to achieve 3a, so a compromise had to be found. To optimise the reaction outcome, a study of the nhexane concentration (3-20% v v -1 ) was carried out ( Figure 1 ). As expected, it was observed that at higher percentages of the organic co-solvent, less quantity of by-products was formed although going in hand with a lower cyclisation rate. Hence, 5% v v -1 of n-hexane was the compromise concentration. In these conditions, we observed a clean reaction with complete consumption of 1a and a promising 42% of 3a after 24 h. In an attempt to maximise the oxirane formation, it was designed a thermally controlled experiment consisting of the enzymatic bioreduction at 30ºC followed by the intramolecular S N 2 transformation at 45ºC by simply setting a temperature program. Thus, the reaction progress at 30ºC was studied (Figure 2 ) to check the time needed to consume α-bromoketone 1a. As can be noted after 12 h this compound disappeared, only forming traces (<2%) of diol 5a. Thus, employing a program that comprised 13 h at 30ºC followed by 18 h at 45ºC excellent epoxide conversion was achieved (Table 1 ). This one-pot sequential process enabled the formation of enantiopure (S)-or (R)-3a with excellent yields by simple selection of the biocatalyst, using either LBADH (entry 2) or ADH from Thermoanaerobacter sp. [15] (ADH-T, entry 3), respectively. Since this one-pot two-step procedure rendered excellent results for this aliphatic substrate, we decided to apply this methodology with an aromatic ketone such as α-bromo-p-nitroacetophenone (1b), obtaining with ADH-T a complete conversion of enantiopure (R)-p-nitrostyrene oxide (3b), and a conversion of 84% and >99% ee of (S)-3b using LBADH (Table 1 , entries 4-5). For this derivative a slightly lower pH (9.5) was chosen, since at pH 10 higher amounts of by-products were detected. Furthermore, taking benefit from the versatility of the medium parameters, we can use this methodology to synthesise selectively the corresponding bromohydrins with high conversions and optical purities. Since it was observed in previous experiments that lower pHs and the presence of an organic co-solvent diminished the cyclisation rate, we exploited this to obtain the bromohydrins 2a-b (Scheme 3). Therefore, experiments were carried out at lower pH (7-7.5) and 30ºC with 5% v v -1 n-hexane (entries 7-10). Thus, enantiopure derivatives (S)-and (R)-2a-b were preferentially obtained using both ADHs. To show the feasibility of these protocols, enantiopure (S)-alcohol 2a and (S)-epoxide 3a were prepared on a higher scale starting from 120 mg of the α-bromoketone 1a with excellent isolated yields (see SI).
At this point we were interested in applying this methodology to obtain other valuable derivatives. Enantiopure prolinol and related structures are important chiral auxiliaries in hydrogen transfer protocols as well as asymmetric epoxidations and catalysts in aldol condensations, Michael type additions and other C-C bond-forming reactions. [16] Moreover, chiral N-containing heterocycles are quite common in natural alkaloids and derivatives, [17] and therefore, it becomes interesting to develop new strategies for their preparation. [18] Epoxides and halohydrins are considered as similar chemical functionalities but they can offer different features that can be exploited chemoselectively. To show this, 5-azido-1-bromopentan-2-one (1c) was reduced with LBADH, affording enantiopure bromohydrin 2c or epoxide 3c in high conversions (Table 1 , entries 6 and 10). These reactions were performed at 100 mgscale obtaining similar results. It was envisaged that these derivatives could be reduced to the highly reactive (non isolated) amino compounds that would spontaneously cyclisise [19] affording prolinol or piperidin-3-ol through S N 2 reactions (Scheme 4). We firstly decided to optimise the reduction step using some reducing reagents such as NaBH 4 and H 2 -Pd/C but in case of 3c the oxirane moiety was unstable. However, by means of the Staudinger reaction using PPh 3 and H 2 O, [20] the desired reduction was successfully accomplished. In case of the amino epoxide, it spontaneously evolved into prolinol with inversion of the configuration following a 5-Exo-Tet process, instead of piperidin-3-ol through an impeded 6-Endo-Tet route according to Baldwin" rules (Scheme 4, left). [21] On the other hand, bromohydrin 2c afforded the piperidine derivative as the sole product through a favoured 6-Exo-Tet pathway (Scheme 4, right). [21] Once optimised all individual steps, enantiopure (R)-prolinol and (S)-piperidin-3-ol were obtained as the corresponding N-Boc and NCBz derivatives, respectively, through this three-step procedure. These transformations could be performed following a one-pot protocol, although better yields were achieved when the Staudinger reduction was performed after isolation of (S)-2c or (S)-3c. This procedure shows an elegant chemodivergent strategy that can be applied to the synthesis of different heterocyclic-bearing scaffolds with good yields and optical purities. In conclusion, we have developed an efficient onepot chemo-and stereodivergent enzymatic process applied to the preparation of both enantiopure terminal epoxides or -bromo alcohols starting from the corresponding α-bromoketones just tuning the reaction conditions. This is a nice example of the application of the medium engineering [22] to an enzymatic process to perform transformations using mild reaction conditions to achieve the selective formation of several derivatives in high yields choosing the stereochemistry by employing the appropriate biocatalyst. Furthermore, applying this chemodivergent methodology very interesting compounds such as prolinol or piperidin-3-ol could readily be synthesised. Other heterocycles may be prepared by selecting the suitable precursor. A more comprehensive study of the presented system is currently under way in our laboratories.
Experimental Section
Synthesis of (S)-N-CBz-piperidin-3-ol (S)-7. [23] 100 mg of 1c were incubated in Tris.SO 4 buffer 50 mM pH 7.5 (20 mL) containing NADPH (1 mM) and MgBr 2 (1 mM) in the presence of 2-propanol (5% v v -1 ) and n-hexane (5% v v -1 ) with LBADH (10 U) for 18 h at 30 ºC. The reaction was extracted with Et 2 O (3 x 5 mL) and the organic layers were dried and evaporated. The crude was dissolved in THF (4 mL), and PPh 3 (2 equiv.) and H 2 O (2 equiv.) were added. The reaction was stirred for 24 h at room temperature. Then, the solvent was evaporated and the crude was extracted with CH 2 Cl 2 /HCl 3N. The aqueous phase obtained (10 mL) was set to pH 8-9 with a satd. solution of Na 2 CO 3 3N and then CH 2 Cl 2 (5 mL) and CBz-Cl (1.2 equiv.) were added and the biphasic system was stirred for 12 h. The crude was extracted with CH 2 Cl 2 and was subjected to flash chromatography over silica gel eluted with EtOAc/CH 2 Cl 2 (from 1:1 to 2:1) affording enantiopure (S)-7 (40%). 1 C 6 ), 50.6 (CH 2 , C 2 ), 65.8 (CH, C 3 ), 67.9 (CH 2 , C b ), 127.7 (C, C i ), 127.9 (2 CH, C m ), 128.4 (2 CH, C o ), 136.6 (CH, C p ) and 155.6 (C, C=O).
